News

Filter

Current filters:

PaxilGlaxoSmithKline

1 to 9 of 160 results

US appeals court reverses paroxetine order in favor of Mylan

23-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) today (July 23) announced that the US Third Circuit Court of…

ApotexGenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalNorth AmericaparoxetinePatentsPaxil

UK's OFT accuses GlaxoSmithKline of "market abuse"

19-04-2013

The UK's Office of Fair Trading (OFT) today (April 19) issued a Statement of Objections to certain pharmaceutical…

AlpharmaEuropeGenericsGlaxoSmithKlineLegalMarkets & MarketingNeurologicalNorton HealthcarePaxilPharmaceuticalPricingSeroxat

Drugs may ease depression without worsening motor problems for PD patients

12-04-2012

Certain antidepressants appear to decrease depression in people with Parkinson's disease without worsening…

Effexor XRGlaxoSmithKlineNeurologicalparoxetinePaxilPfizerPharmaceuticalResearchvenlafaxine

GlaxoSmithKline paid $1 billion in Paxil suits; reveals fees to US consultants

15-12-2009

GlaxoSmithKline, the world’s second-largest drugmaker, has paid nearly $1 billion to resolve law…

FinancialGlaxoSmithKlineGSKLillyNeurologicalNorth AmericaparoxetinePaxilPharmaceuticalPolitics

1 to 9 of 160 results

COMPANY SPOTLIGHT

Menarini

Back to top